LO SIMPESSE Drug Patent Profile
When do Lo Simpesse patents expire, and when can generic versions of Lo Simpesse launch?
Lo Simpesse is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in LO SIMPESSE is ethinyl estradiol; levonorgestrel. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LO SIMPESSE?
- What are the global sales for LO SIMPESSE?
- What is Average Wholesale Price for LO SIMPESSE?
Summary for LO SIMPESSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | LO SIMPESSE at DailyMed |
Recent Clinical Trials for LO SIMPESSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexion Pharmaceuticals, Inc. | Phase 1 |
US Patents and Regulatory Information for LO SIMPESSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | LO SIMPESSE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 206852-001 | Apr 28, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
